To qualify, you need to meet one of the following requirements when starting GLP-1 treatment: A BMI (body mass index) of 35 or higher A BMI between 30 and 34.99, with one or more additional conditions: Diastolic heart failure Uncontrolled high blood pressure/hypertension Chronic kidney disease, stage 3a or higher Prediabetes Previous heart attack or stroke Blocked arteries in arms or legs with symptoms A BMI between 27 and 29.99, with one or more additional conditions: Prediabetes Previous heart attack or stroke Blocked arteries in arms or legs with symptoms Medicare beneficiaries who have sleep apnea, diabetes or fatty liver disease can't access the program, but their Medicare Part D insurance might cover their GLP-1s separately based on those diagnoses
Even at refrigerator temperatures, its potency will begin to decline
National Academies of Sciences E
A small randomized controlled trial ( N = 40) showed that 6-month dapagliflozin treatment was associated with a significant reduction in EAT volume compared to baseline, with no changes in the control group [43]
Now, leading medical organizations like the World Health Organization recognize obesity as a chronic medical condition that can drive numerous other health ailments such as diabetes, heart disease, kidney disease and potentially even cancer
Your provider will adjust based on how you feel and any lab guidance